Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).

The Peptide Craze – What You Need to Know

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

Oral Contraceptives on the PBS – A Practical Guide for GPs

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility

expert
GP Supervisor with a special interest in Heart Failure, ASCVD and Diabetes, Marketown Health; Conjoint lecturer, University of Newcastle